GC-MS Profiling and Neuroprotective Potential of <i>Sida mysorensis</i>: <i>In Vitro</i> Antioxidant and Acetylcholinesterase Inhibitory Activities for Alzheimer�s Disease Management

Background: Oxidative stress is a major contributing factor in the pathogenesis of Alzheimer's Disease (AD). Medicinal plants are increasingly explored as sources of natural antioxidants and cholinesterase inhibitors to mitigate oxidative damage and manage AD. Sida mysorensis has shown notable therapeutic potential due to its rich phytochemical composition. Aim: To investigate the pharmacognostical and phytochemical characteristics, antioxidant potential, and anti-cholinesterase activity of chloroform and ethanolic extracts of S. mysorensis. Methods: Antioxidant activity was evaluated using ABTS, hydrogen peroxide (H2O2), and DPPH radical scavenging assays. Acetylcholinesterase (AChE) inhibition was assessed to determine neuroprotective potential. Total phenolic and flavonoid contents were quantified. The chloroform extract (CESM), which exhibited superior activity, underwent GC-MS analysis to identify its phytochemical constituents. Results: CESM was rich in phenols (63.90 mg GAE/g) and flavonoids (37.68 mg QE/g) and demonstrated potent antioxidant activity with IC50 values of 21.08 ?g/mL (ABTS), 30.98 ?g/mL (H2O2), and 35.06 ?g/mL (DPPH), surpassing the standard. CESM also showed significant AChE inhibitory activity (IC50 = 132.46 ?g/mL), suggesting potential in AD-related neurodegeneration management. GC-MS profiling identified over 38 phytochemicals with retention times ranging from 3.96 to 37.5 minutes. Conclusion: The study confirms S. mysorensis, particularly its chloroform extract, as a promising source of natural antioxidants and cholinesterase inhibitors. Its potent in vitro bioactivities highlight its potential for AD treatment, warranting further research to isolate and characterize the active compounds responsible for these effects. Major Findings: The Chloroform Extract of S. mysorensis (CESM) demonstrated significant antioxidant activity (IC50: 21.08-35.06 ?g/mL) and potent acetylcholinesterase inhibition (IC50: 132.46 ?g/mL), correlating with its hi

View article page

Download PDF